These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 8097689

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C, Gelboin HV, Park SS, Pearce R, Parkinson A, Kupfer D.
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases.
    Hammons GJ, Guengerich FP, Weis CC, Beland FA, Kadlubar FF.
    Cancer Res; 1985 Aug; 45(8):3578-85. PubMed ID: 4016738
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase.
    Kedderis GL, Rickert DE.
    Drug Metab Dispos; 1985 Aug; 13(1):58-61. PubMed ID: 2858378
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Asymmetric metabolic N-oxidation of N-ethyl-N-methylaniline by purified flavin-containing monooxygenase.
    Hadley MR, Oldham HG, Damani LA, Hutt AJ.
    Chirality; 1994 Aug; 6(2):98-104. PubMed ID: 8204419
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies on N-demethylation of methamphetamine by liver microsomes of guinea-pigs and rats: the role of flavin-containing mono-oxygenase and cytochrome P-450 systems.
    Yamada H, Baba T, Hirata Y, Oguri K, Yoshimura H.
    Xenobiotica; 1984 Nov; 14(11):861-6. PubMed ID: 6506758
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enantioselective N-oxygenation of verapamil by the hepatic flavin-containing monooxygenase.
    Cashman JR.
    Mol Pharmacol; 1989 Sep; 36(3):497-503. PubMed ID: 2779529
    [Abstract] [Full Text] [Related]

  • 14. Flavin-containing monooxygenase-mediated metabolism of N-deacetyl ketoconazole by rat hepatic microsomes.
    Rodriguez RJ, Proteau PJ, Marquez BL, Hetherington CL, Buckholz CJ, O'Connell KL.
    Drug Metab Dispos; 1999 Aug; 27(8):880-6. PubMed ID: 10421614
    [Abstract] [Full Text] [Related]

  • 15. Role of cytochrome P-450 and flavin-containing monooxygenase in the N-hydroxylation of N-methyl-4-aminoazobenzene in rat liver: analysis with purified enzymes and antibodies.
    Kimura T, Kodama M, Nagata C.
    Gan; 1984 Oct; 75(10):895-904. PubMed ID: 6510637
    [Abstract] [Full Text] [Related]

  • 16. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT, Wu YS, Chang YW, Hsieh HP, Chen WC, Lan SJ, Chen CT, Chao YS, Chang L, Sun HY, Yeh TK.
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [Abstract] [Full Text] [Related]

  • 17. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
    Loughran PA, Roman LJ, Miller RT, Masters BS.
    Arch Biochem Biophys; 2001 Jan 15; 385(2):311-21. PubMed ID: 11368012
    [Abstract] [Full Text] [Related]

  • 18. [Effect of monooxygenase reactions catalyzed by cytochrome P-450 on the microsomal membrane].
    Karuzina II, Mengazetdinov DE, Kapitanov AB, Zhukov AA, Ivanova LI.
    Biokhimiia; 1987 Jul 15; 52(7):1090-6. PubMed ID: 3663748
    [Abstract] [Full Text] [Related]

  • 19. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease.
    Coleman T, Ellis SW, Martin IJ, Lennard MS, Tucker GT.
    J Pharmacol Exp Ther; 1996 May 15; 277(2):685-90. PubMed ID: 8627546
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.